Frontiers in Pharmacology | Inflammation Pharmacology

Editorial

Published on 09 Feb 2023

Editorial: Leukocyte biology and muscle pathology: Leukocytes as potential targets to control muscle inflammation, mass, and pain

in Inflammation Pharmacology

Miriam S. N. Hohmann
Waldiceu A. Verri
Flavia A. Guarnier
Barbara St. Pierre Schneider
Sergio M. Borghi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154559

1,513 views

Review

Published on 07 Feb 2023

Advances in the mechanisms and applications of inhibitory oligodeoxynucleotides against immune-mediated inflammatory diseases

in Inflammation Pharmacology

Hongrui Wang
Yingying Su
Duoduo Chen
Qi Li
Shuyou Shi
Xin Huang
Mingli Fang
Ming Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119431

3,315 views
6 citations

Editorial

Published on 02 Feb 2023

Editorial: Acute phase proteins as biomarkers and therapeutics in acute and chronic inflammatory conditions

in Inflammation Pharmacology

Frauke Stanke
Sabina Janciauskiene
Beata Olejnicka

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1145990

1,760 views
1 citation

Systematic Review

Published on 30 Jan 2023

Association between vitamin A and asthma: A meta-analysis with trial sequential analysis

in Inflammation Pharmacology

Jun Hu
Jiajia Sang
Feng Hao
Li Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1100002

4,872 views
14 citations

Review

Published on 25 Jan 2023

Title: Immunotherapy; a ground-breaking remedy for spinal cord injury with stumbling blocks: An overview

in Inflammation Pharmacology

Yasmeen Saeed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1110008

3,200 views
3 citations

Mini Review

Published on 23 Jan 2023

Self-reactive IgE and anti-IgE therapy in autoimmune diseases

in Inflammation Pharmacology

Anna Olewicz-Gawlik
Arleta Kowala-Piaskowska

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1112917

19,152 views
10 citations

Mini Review

Published on 20 Jan 2023

Cholesterol metabolism in the regulation of inflammatory responses

in Inflammation Pharmacology

Rebekka Bauer
Bernhard Brüne
Tobias Schmid

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1121819

9,173 views
25 citations

Original Research

Published on 20 Jan 2023

Sal003 alleviated intervertebral disc degeneration by inhibiting apoptosis and extracellular matrix degradation through suppressing endoplasmic reticulum stress pathway in rats

in Inflammation Pharmacology

Yan Chen
Baixing Li
Yue Xu
Tangjun Zhou
Changqing Zhao
Jie Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095307

3,172 views
7 citations

Review

Published on 19 Jan 2023

Traditional Chinese medicine for treatment of sepsis and related multi-organ injury

in Inflammation Pharmacology

Yaqin Song
Weiji Lin
Wei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1003658

18,094 views
36 citations

Correction

Published on 18 Jan 2023

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

in Inflammation Pharmacology

Mingming Fan
Huijuan Xiao
Dingyun Song
Lili Zhu
Jie Zhang
Xinran Zhang
Jing Wang
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1109002

1,854 views

Correction

Published on 18 Jan 2023

Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

in Inflammation Pharmacology

Mingming Fan
Huijuan Xiao
Dingyun Song
Lili Zhu
Jie Zhang
Xinran Zhang
Jing Wang
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1108989

1,979 views
2 citations

Review

Published on 17 Jan 2023

Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine

in Inflammation Pharmacology

Rui Tian
Lin Yuan
Yuan Huang
Rui Zhang
Hao Lyu
Shuai Xiao
Dong Guo
Declan William Ali
Marek Michalak
Xing-Zhen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053602

7,228 views
7 citations

Original Research

Published on 16 Jan 2023

Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn’s disease

in Inflammation Pharmacology

Kouzhu Zhu
Xiaoliang Ding
Zhiyao Chen
Qinhua Xi
Xueqin Pang
Weichang Chen
Liyan Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1096816

2,766 views
7 citations

Review

Published on 16 Jan 2023

Targeting type I interferons in systemic lupus erythematous

in Inflammation Pharmacology

Sebastian Bruera
Thandiwe Chavula
Riya Madan
Sandeep K. Agarwal

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1046687

12,558 views
33 citations

Original Research

Published on 13 Jan 2023

Neutralization of excessive CCL28 improves wound healing in diabetic mice

in Inflammation Pharmacology

Zhenlong Chen
Jacob M. Haus
Luisa A. DiPietro
Timothy J. Koh
Richard D. Minshall

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1087924

4,454 views
9 citations

Original Research

Published on 13 Jan 2023

Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling

in Inflammation Pharmacology

Xu Yan
Tianjiao Lin
Qingyun Zhu
Yushi Zhang
Zhimin Song
Xinting Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090261

4,608 views
24 citations